A

avVaa World Health Care Products Inc
OTC:AVVH

Watchlist Manager
avVaa World Health Care Products Inc
OTC:AVVH
Watchlist
Price: 0.0024 USD -20% Market Closed
Market Cap: $2.3m

Balance Sheet

Balance Sheet Decomposition
avVaa World Health Care Products Inc

Balance Sheet
avVaa World Health Care Products Inc

Rotate your device to view
Balance Sheet
Currency: USD
May-2004 May-2005 May-2006 May-2007 May-2008 May-2009 May-2010 May-2011 May-2012 May-2013
Assets
Cash & Cash Equivalents
0
0
1
0
0
0
0
0
0
0
Cash
0
0
1
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
Total Current Assets
0
0
1
0
0
0
0
0
0
0
PP&E Net
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
0
N/A
1
+111%
2
+190%
1
-63%
0
-78%
0
-77%
0
+47%
0
-69%
0
-97%
0
+25 650%
Liabilities
Accounts Payable
1
1
1
1
1
1
1
1
1
1
Accrued Liabilities
0
0
0
6
10
11
4
4
4
4
Short-Term Debt
0
0
0
0
2
3
4
5
5
5
Other Current Liabilities
0
1
1
7
14
8
7
3
3
3
Total Current Liabilities
2
2
3
13
27
22
15
13
13
13
Long-Term Debt
0
0
1
1
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
Total Liabilities
2
N/A
2
+25%
4
+67%
15
+288%
27
+84%
22
-19%
15
-29%
13
-15%
13
0%
13
+0%
Equity
Common Stock
0
0
0
0
0
1
2
2
2
2
Retained Earnings
4
7
11
23
36
35
33
31
31
31
Additional Paid In Capital
3
7
10
9
10
13
16
16
16
16
Other Equity
1
1
1
0
0
0
0
0
0
0
Total Equity
2
N/A
2
-9%
2
-23%
14
-585%
27
-91%
22
+18%
15
+29%
13
+15%
13
N/A
13
+1%
Total Liabilities & Equity
0
N/A
1
+111%
2
+190%
1
-63%
0
-78%
0
-77%
0
+47%
0
-69%
0
-97%
0
+25 650%
Shares Outstanding
Common Shares Outstanding
0
0
1
4
7
853
1 672
1 672
1 672
1 883
Preferred Shares Outstanding
0
0
0
0
5
198
1
1
1
1
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett